share_log

Analysts Are Updating Their Wanhua Chemical Group Co., Ltd. (SHSE:600309) Estimates After Its Yearly Results

Analysts Are Updating Their Wanhua Chemical Group Co., Ltd. (SHSE:600309) Estimates After Its Yearly Results

分析师正在公布年度业绩后更新其万华化学集团有限公司(SHSE: 600309)的估计
Simply Wall St ·  03/20 19:03

Last week saw the newest yearly earnings release from Wanhua Chemical Group Co., Ltd. (SHSE:600309), an important milestone in the company's journey to build a stronger business. Revenues of CN¥175b were in line with forecasts, although statutory earnings per share (EPS) came in below expectations at CN¥5.36, missing estimates by 3.5%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

上周,万华化学集团有限公司(SHSE: 600309)发布了最新的年度财报,这是公司建立更强大业务过程中的一个重要里程碑。尽管法定每股收益(EPS)低于预期,为5.36元人民币,比预期低3.5%,但收入为1750亿元人民币,与预期一致。对于投资者来说,盈利是一个重要时刻,因为他们可以追踪公司的业绩,查看分析师对明年的预测,看看对公司的情绪是否发生了变化。考虑到这一点,我们收集了最新的法定预测,以了解分析师对明年的预期。

earnings-and-revenue-growth
SHSE:600309 Earnings and Revenue Growth March 20th 2024
SHSE: 600309 2024 年 3 月 20 日收益和收入增长

Taking into account the latest results, the current consensus from Wanhua Chemical Group's 21 analysts is for revenues of CN¥199.7b in 2024. This would reflect a decent 14% increase on its revenue over the past 12 months. Per-share earnings are expected to bounce 20% to CN¥6.45. In the lead-up to this report, the analysts had been modelling revenues of CN¥199.5b and earnings per share (EPS) of CN¥6.65 in 2024. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a small dip in their earnings per share forecasts.

考虑到最新业绩,万华化学集团的21位分析师目前的共识是,2024年的收入为1997亿元人民币。这将反映其收入在过去12个月中大幅增长了14%。每股收益预计将反弹20%,至6.45元人民币。在本报告发布之前,分析师一直在模拟2024年的收入为199.5亿元人民币,每股收益(EPS)为6.65元人民币。因此,在最近的业绩公布之后,整体情绪似乎略有下降——收入估计没有重大变化,但分析师的每股收益预测确实略有下降。

It might be a surprise to learn that the consensus price target was broadly unchanged at CN¥108, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Wanhua Chemical Group, with the most bullish analyst valuing it at CN¥125 and the most bearish at CN¥95.00 per share. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

得知共识目标股价基本保持不变,为108元人民币,这可能会令人惊讶,分析师明确表示,预期的收益下降预计不会对估值产生太大影响。研究分析师的估计范围,评估异常值与平均值的差异程度也可能很有启发性。对万华化学集团的看法有所不同,最看涨的分析师将其估值为125元人民币,最看跌的为每股95.00元人民币。尽管如此,由于估计范围如此之窄,这表明分析师对他们认为该公司的价值有了很好的了解。

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Wanhua Chemical Group's revenue growth is expected to slow, with the forecast 14% annualised growth rate until the end of 2024 being well below the historical 24% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 18% per year. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Wanhua Chemical Group.

了解这些预测的更多背景信息的一种方法是研究它们与过去的业绩相比如何,以及同一行业中其他公司的表现。我们要强调的是,万华化学集团的收入增长预计将放缓,预计到2024年底的年化增长率为14%,远低于过去五年24%的历史年增长率。相比之下,该行业中其他有分析师报道的公司的收入预计将以每年18%的速度增长。因此,很明显,尽管收入增长预计将放缓,但整个行业的增长速度预计也将超过万华化学集团。

The Bottom Line

底线

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Wanhua Chemical Group. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at CN¥108, with the latest estimates not enough to have an impact on their price targets.

最大的担忧是,分析师下调了每股收益预期,这表明万华化学集团可能会面临业务不利因素。从好的方面来看,收入估计没有重大变化;尽管预测表明它们的表现将比整个行业差。共识目标股价稳定在108元人民币,最新估计不足以对其目标股价产生影响。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Wanhua Chemical Group going out to 2026, and you can see them free on our platform here..

考虑到这一点,我们仍然认为该业务的长期发展轨迹对于投资者来说更为重要。在Simply Wall St,我们有分析师对万华化学集团到2026年的全方位估计,你可以在我们的平台上免费看到这些估计。

Plus, you should also learn about the 3 warning signs we've spotted with Wanhua Chemical Group (including 1 which is a bit concerning) .

另外,您还应该了解我们在万华化学集团发现的3个警告信号(其中一个有点令人担忧)。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发